Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000223978 | SCV000281610 | uncertain significance | not provided | 2015-11-23 | criteria provided, single submitter | clinical testing | Converted during submission to Uncertain significance. |
Athena Diagnostics | RCV001640370 | SCV001142962 | likely benign | not specified | 2020-09-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000223978 | SCV001811985 | likely benign | not provided | 2021-01-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000223978 | SCV002401782 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000223978 | SCV004125750 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | COQ8A: BS1 |
Mayo Clinic Laboratories, |
RCV000223978 | SCV005410079 | uncertain significance | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | BP4 |
Prevention |
RCV003955293 | SCV004770482 | likely benign | COQ8A-related disorder | 2021-09-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |